New eye injection schedules tested to fight blinding disease
NCT ID NCT07365371
Summary
This study is testing two different treatment schedules for aflibercept 8mg injections in the eye to control Polypoidal Choroidal Vasculopathy (PCV), a condition that can cause vision loss. It aims to see which schedule is better at improving and maintaining vision over one year while requiring fewer injections. The study will enroll 174 Chinese patients who have not received prior treatment for PCV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Eye Hospital of Nanchang University
Nanchang, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Affiliated Hospital Of Shandong Second Medical University
Weifang, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beijing Hospital
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Beijing Tongren Hospital, CMU
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiangsu Province Hospital , The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jiaxing Hospital of T.C.M
Jiaxing, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Renmin Hospital Of Wuhan University
Wuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shandong Provincial Hospital
Jinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
-
Shanxi Eye Hospital
Taiyuan, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital Of Harbin Medical University
Harbin, Heilongjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First People's Hospital Of Xianyang
Xianyang, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Norman Bethune Hospital Of Jilin University
Jilin, Jilin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second People's Hospital Of Foshan
Foshan, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Eye Hospital
Tianjin, Tianjin Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xi' AN No.1 Hospital
Xi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.